J0577 HCPCS Level II code: Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
J0577 is the HCPCS code for “Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
Short description: Inj, brixadi, 7 days or less
HCPCS · United States
Medicare details
The indicators CMS publishes with J0577 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Apr 1, 2024
Where J0577 sits
- 1J codesDrugs administered other than orally
- 2Active code J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0577 mean?
J0577 is the HCPCS code for “Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0577?
CMS lists J0577’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0577
All J codesJ0571Buprenorphine, oral, 1 mgJ0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphineJ0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphineJ0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphineJ0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphineJ0576Injection, buprenorphine extended-release (brixadi), 1 mgJ0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapyJ0582Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mgJ0583Injection, bivalirudin, 1 mgJ0584Injection, burosumab-twza 1 mgJ0585Injection, onabotulinumtoxina, 1 unitJ0586Injection, abobotulinumtoxina, 5 units